$PL

Raymond John w sold $170K of PL (indirect holdings)

Raymond John w sold 6,494 indirectly-held shares of Planet Labs PBC (PL) at $26.16 ($0.17M total) on 2026-07-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Raymond John w
Published Jul 14, 2026, 9:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 14, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PL
Neutral
high confidence
Mentioned
$PL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price ($26.1582), and post-transaction holdings (37,114 shares), under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for clustering of insider sales, but this single planned sale is unlikely to drive a material repricing.

03

What to watch

The transaction is indirect and under a 10b5-1 plan; without additional context (other sales, option exercises, or changes in holdings), it is hard to infer directionality.

Relevance 3/10Novelty 3/10Timing: Filed on 2026-07-14, covering a sale executed on 2026-07-13.

Background

The article is an SEC Form 4 insider transaction disclosure for Planet Labs PBC, reported by director Raymond John W.

Company-level read

Ticker impact

$PLNeutralHigh confidence
Context

Raymond John W, a Planet Labs director, sold 6,494 shares in an open-market transaction under a 10b5-1 plan, worth about $169.9K.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and small versus normal trading volume.

Evidence & confidence

The filing is an SEC Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the disclosed value ($169.9K) is modest relative to typical market moves.

Market effects

No clear sector read-through; this is company-specific insider trading with no operational or guidance content.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with private views on valuation or liquidity needs, so some traders may treat it as mild bearish sentiment.

Key entities

  • Planet Labs PBC

    Subject of the Form 4 insider transaction disclosure.

  • Raymond John W

    Director who sold shares via an open-market transaction under a 10b5-1 plan.

Related articles

$PLMed

Scottish Government Selects Planet Labs PBC for AI-Enabled Monitoring to Support Sustainable Agricultural Reform

Planet Labs PBC (NYSE: PL) said the Scottish Government selected it for a one-year, seven-figure award via Computacenter to provide PlanetScope satellite data and analytics for Scotland’s Agricultural Reform Route Map. The program runs through 2026 to support monitoring for biodiversity, food production, and carbon-emissions targets, according to Planet.

$PLMed

Planet Labs Rallies on Renewed Optimism in Space Stocks Following the Rocket Lab-Iridium Partnership

Planet Labs said it extended an NGA contract under the Luno B IDIQ framework, adding a one-year $22M option for Maritime Domain Awareness and a new Global Monitoring Service award for crisis response. It shipped Pelican 11 to Vandenberg for a SpaceX Transporter 17 launch and shared AIRS reentry data with the University of Southampton. Next earnings are Sept. 14; Q2 revenue guidance is $102–$107M and analysts’ average target is $41.